Results 111 to 120 of about 8,452 (228)

Advancing the use of real world evidence in health technology assessment: insights from a multi-stakeholder workshop

open access: yesFrontiers in Pharmacology
Introduction: Real-world evidence (RWE) in health technology assessment (HTA) holds significant potential for informing healthcare decision-making. A multistakeholder workshop was organised by the European Health Data and Evidence Network (EHDEN) and the
Ravinder Claire   +8 more
doaj   +1 more source

Bias‐Triggered Conductivity Relaxation (BCR): A Unique Tool to Simultaneously Investigate Thermodynamics, Kinetics, and Electrostatic Effects of Oxygen Reactions in MIEC Thin Films

open access: yesAdvanced Materials, Volume 38, Issue 43, 3 August 2026.
This work develops bias‐triggered conductivity relaxation as a novel technique to study oxygen reactions in mixed ionic‐electronic conducting thin films by integrating electrochemical titration and electrical conductivity relaxation to achieve synchronous multi‐parameter characterization, providing simultaneous electronic, ionic, and extraordinarily ...
Alexander Stangl   +4 more
wiley   +1 more source

Der Eon/RWE-Deal : Marktbeherrschung und Shareholder Value-Politik mit behördlicher Zustimmung [PDF]

open access: yes, 2020
Am 17. September 2019 hat die EU-Wettbewerbs-Kommissarin Margrethe Vestager dem Stromkonzern Eon die Übernahme und Zerschlagung der RWE-Tochter Innogy unter leichten Auflagen erlaubt.
Berlo, Kurt, Wagner, Oliver
core  

Real‐World Evaluation of Talquetamab for the Treatment of Relapsed/Refractory Multiple Myeloma (RRMM): An International Myeloma Working Group Immunotherapy Registry Real‐World Analysis

open access: yesAmerican Journal of Hematology, Volume 101, Issue 8, Page 1928-1937, August 2026.
ABSTRACT Talquetamab is a GPRC5D × CD3 bispecific antibody approved for relapsed/refractory multiple myeloma (RRMM). This is the first real‐world study to comprehensively report muco‐cutaneous toxicities, infections, and efficacy of talquetamab in 151 patients across five countries with the longest follow‐up reported enabling better efficacy and ...
Murali Janakiram   +94 more
wiley   +1 more source

RWE AG Geschaeftsbericht 1989/90 [PDF]

open access: yes, 1991
SIGLECopy held by FIZ Karlsruhe; available from UB/TIB Hannover / FIZ - Fachinformationszzentrum Karlsruhe / TIB - Technische ...
Rheinisch-Westfaelisches Elektrizitaetswerk A.G. (RWE), Essen (Germany)
core  

Generalizability in real‐world trials

open access: yesClinical and Translational Science
Real‐world evidence (RWE) trials have a key advantage over conventional randomized controlled trials (RCTs) due to their potentially better generalizability.
Anatol‐Fiete Näher   +3 more
doaj   +1 more source

Systematic Evaluation of Data and Trial Fitness for Oncology Trial Emulation: Empirical Findings from the CARE Initiative

open access: yesClinical Pharmacology &Therapeutics, Volume 120, Issue 2, Page 440-451, August 2026.
The Coalition to Advance Real‐World Evidence through Randomized Controlled Trial Emulation (CARE) Initiative seeks to advance understanding of when real‐world data (RWD) can generate valid treatment effectiveness estimates by emulating completed oncology randomized controlled trials (RCTs).
Natalie Levy   +42 more
wiley   +1 more source

Constructing Policy (In)coherence in Germany's Energy Transition and Impacts on (In)equality

open access: yesEnvironmental Policy and Governance, Volume 36, Issue 4, Page 1034-1048, August 2026.
ABSTRACT Policy coherence is widely regarded as essential for achieving sustainable development, climate targets, and reducing inequality, as reflected in the 2030 Agenda for Sustainable Development. Recent scholarship has moved beyond technocratic approaches, drawing on comparative politics, particularly the “3 I's” of ideas, interests, and ...
Alexia Faus Onbargi, Ines Dombrowsky
wiley   +1 more source

RETRACTED: ESMO Guidance for reporting oncology real-world evidence (GROW)

open access: yesРеальная клиническая практика: данные и доказательства
RETRACTED ARTICLEThe European Society for Medical Oncology (ESMO) has produced the very first expert-based guidance for reporting real-world evidence (RWE) studies specifically for oncology.
A. Sh. Motrinchuk, A. A. Kurylev
doaj   +1 more source

Real‐world‐data for phenotypes and genotypes of rare monogenic genetic epilepsies and genes of uncertain significance for epilepsy

open access: yesEpilepsia Open, Volume 11, Issue 4, Page 1184-1199, August 2026.
Abstract Objectives The objectives of this study were to develop a real‐world‐data (RWD) database for patients with epilepsy to provide further real‐world‐evidence (RWE) for monogenic genetic epilepsies; to assess the usefulness of a diagnostic algorithm in epilepsy; and to examine protein 3D structures using in silico tools to predict variant ...
Haley Morris   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy